Co-careldopa (Carbidopa/levodopa) Prescribing at SAFFRON GROUP PRACTICE
Drugs used in parkinsonism and related disorders | Central Nervous System
Items (12m)
305
Total Quantity
33.3K
NHS Cost
£2.2K
vs National Avg
+35%
SAFFRON GROUP PRACTICE prescribed 305 items of Co-careldopa (Carbidopa/levodopa) over the last 12 months at a cost of £2,249 to the NHS. This is 35% above the national average prescribing rate. Co-careldopa (Carbidopa/levodopa) is classified under Drugs used in parkinsonism and related disorders in the BNF.
Monthly Prescribing Trend
Jul 2026
36
Jul 2026
23
Jul 2026
25
Jul 2026
27
Jul 2026
22
Jul 2026
25
Jul 2026
23
Jul 2026
22
Jul 2026
22
Jul 2026
24
Jul 2026
28
Jul 2026
28
Prescribing Details
| Total Items | 305 |
|---|---|
| Total Quantity | 33,318 |
| Total NHS Cost | £2,249 |
| Presentations | 8 different forms |
| vs National Average | +35% |
Co-careldopa (Carbidopa/levodopa) Prescribing Comparison
| This practice | 305 items |
|---|---|
| National average per practice | 226 items |
| Difference | +35% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.